Eterna Therapeutics, based in New York, NY, is a pioneering biotech company focused on unlocking the potential of cell engineering for curative and transformative therapies. With over 100 patents developed over the last 12 years, Eterna collaborates with life sciences companies in areas such as cell reprogramming, gene editing, and gene delivery using their proprietary mRNA technology.
Specializing in rare diseases, autoimmune diseases, and oncology, Eterna not only licenses its extensive patent portfolio but also strives to develop therapeutic candidates. Recent announcements include the appointment of Peter Cicala to its board of directors and the induction of Sanjeev Luther as the new President and CEO.
Generated from the website